DOCK8 and COVID-19: Since 45% of the clinical trial participants who underwent WGS possessed mutations in fHLH and/or DOCK8 genes that may have contributed to CSS via partially disrupted NK cell cytolysis, the association of these mutations was compared with the various CSS (general and COVID-19 specific) CSS criteria.